Trial Profile
Response, Resistance and Metastasis of Locally Advanced Breast Cancer (LABC, Stage 2B-3C) in a Multiethnic Cohort: A Phase II International Multicentric Study of Concurrent Paclitaxel and Radiation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 27 Apr 2020 Status changed from active, no longer recruiting to completed.
- 23 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2019.
- 27 Dec 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2018.